Epigenetics in renal cell cancer: mechanisms and clinical applications
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epigenetics in renal cell cancer: mechanisms and clinical applications
Authors
Keywords
-
Journal
Nature Reviews Urology
Volume 15, Issue 7, Pages 430-451
Publisher
Springer Nature
Online
2018-06-04
DOI
10.1038/s41585-018-0023-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Renal mass biopsy for the small renal mass
- (2018) Sapan N. Ambani et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Epigenome Aberrations: Emerging Driving Factors of the Clear Cell Renal Cell Carcinoma
- (2017) Ali Mehdi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trial
- (2017) Hagop M Kantarjian et al. LANCET ONCOLOGY
- TRIM8 restores p53 tumour suppressor function by blunting N-MYC activity in chemo-resistant tumours
- (2017) Francesca Mastropasqua et al. Molecular Cancer
- Epigenetics and immunotherapy: The current state of play
- (2017) Jennifer Dunn et al. MOLECULAR IMMUNOLOGY
- Identification of miR-195-3p as an oncogene in RCC
- (2017) Lu Jin et al. Molecular Medicine Reports
- Hypoxia-induced hsa-miR-101 promotes glycolysis by targeting TIGAR mRNA in clear cell renal cell carcinoma
- (2017) Xiaochao Xu et al. Molecular Medicine Reports
- Identification of miR-30b as an oncogene in renal cell carcinoma
- (2017) Lu Jin et al. Molecular Medicine Reports
- Inactivation of the PBRM1 tumor suppressor gene amplifies the HIF-response in VHL−/−clear cell renal carcinoma
- (2017) Wenhua Gao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MiR-122 promotes renal cancer cell proliferation by targeting Sprouty2
- (2017) Zijie Wang et al. TUMOR BIOLOGY
- Detection of urinary cell-free miR-210 as a potential tool of liquid biopsy for clear cell renal cell carcinoma
- (2017) Guorong Li et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Expression of microRNA-30c via lentivirus vector inhibits the proliferation and enhances the sensitivity of highly aggressive ccRCC Caki-1 cells to anticancer agents
- (2017) Honglin Yang et al. OncoTargets and Therapy
- microRNA-210-3p depletion by CRISPR/Cas9 promoted tumorigenesis through revival of TWIST1 in renal cell carcinoma
- (2017) Hirofumi Yoshino et al. Oncotarget
- The SWI/SNF Protein PBRM1 Restrains VHL-Loss-Driven Clear Cell Renal Cell Carcinoma
- (2017) Amrita M. Nargund et al. Cell Reports
- Recurrence in Localized Renal Cell Carcinoma: a Systematic Review of Contemporary Data
- (2017) Jacqueline M. Speed et al. Current Urology Reports
- Sequential pathogenesis of metastatic VHL mutant clear cell renal cell carcinoma: putting it together with a translational perspective
- (2016) N. Shenoy et al. ANNALS OF ONCOLOGY
- MicroRNA-200a-3p suppresses tumor proliferation and induces apoptosis by targeting SPAG9 in renal cell carcinoma
- (2016) Xinsheng Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- miR-144-3p serves as a tumor suppressor for renal cell carcinoma and inhibits its invasion and metastasis by targeting MAP3K8
- (2016) Fei Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Clinical evaluation of microRNA-145 expression in renal cell carcinoma: a promising molecular marker for discriminating and staging the clear cell histological subtype
- (2016) Emmanuel I. Papadopoulos et al. BIOLOGICAL CHEMISTRY
- Effect of MicroRNA-218 on the viability, apoptosis and invasion of renal cell carcinoma cells under hypoxia by targeted downregulation of CXCR7 expression
- (2016) Shouhua Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- miRNA-133b and miRNA-135a induce apoptosis via the JAK2/STAT3 signaling pathway in human renal carcinoma cells
- (2016) Wenbin Zhou et al. BIOMEDICINE & PHARMACOTHERAPY
- miR-206 functions as a novel cell cycle regulator and tumor suppressor in clear-cell renal cell carcinoma
- (2016) Haibing Xiao et al. CANCER LETTERS
- Combining Epigenetic and Immunotherapy to Combat Cancer
- (2016) Katherine B. Chiappinelli et al. CANCER RESEARCH
- A Four-Gene Promoter Methylation Marker Panel Consisting of GREM1, NEURL, LAD1, and NEFH Predicts Survival of Clear Cell Renal Cell Cancer Patients
- (2016) Iris J.H. van Vlodrop et al. CLINICAL CANCER RESEARCH
- DNA Methylation Signature Reveals Cell Ontogeny of Renal Cell Carcinomas
- (2016) G. G. Malouf et al. CLINICAL CANCER RESEARCH
- Concentration and Methylation of Cell-Free DNA from Blood Plasma as Diagnostic Markers of Renal Cancer
- (2016) Inessa Skrypkina et al. DISEASE MARKERS
- Balanced Translocations Disrupting SMARCB1 Are Hallmark Recurrent Genetic Alterations in Renal Medullary Carcinomas
- (2016) Julien Calderaro et al. EUROPEAN UROLOGY
- MicroRNA-195 targets VEGFR2 and has a tumor suppressive role in ACHN cells via PI3K/Akt and Raf/MEK/ERK signaling pathways
- (2016) Pengcheng Sun et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- miR-19a correlates with poor prognosis of clear cell renal cell carcinoma patients via promoting cell proliferation and suppressing PTEN/SMAD4 expression
- (2016) Qiang Ma et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- MiR-144 inhibits cell proliferation of renal cell carcinoma by targeting MTOR
- (2016) Cheng Xiang et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- miR-206 inhibits renal cell cancer growth by targeting GAK
- (2016) Chao Wei et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- Understanding the epigenetic regulation of tumours and their microenvironments: opportunities and problems for epigenetic therapy
- (2016) Man Liu et al. JOURNAL OF PATHOLOGY
- Downregulation of lncRNA CASC2 by microRNA-21 increases the proliferation and migration of renal cell carcinoma cells
- (2016) YUNJIE CAO et al. Molecular Medicine Reports
- MicroRNA-126 inhibits tumor cell invasion and metastasis by downregulating ROCK1 in renal cell carcinoma
- (2016) GUI-MING ZHANG et al. Molecular Medicine Reports
- Tumor suppressor miR-149-5p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma
- (2016) LU JIN et al. Molecular Medicine Reports
- MicroRNA-22 is downregulated in clear cell renal cell carcinoma, and inhibits cell growth, migration and invasion by targeting PTEN
- (2016) WENXING FAN et al. Molecular Medicine Reports
- Differentially expressed microRNA-218 modulates the viability of renal cell carcinoma by regulating BCL9
- (2016) Jianming Wang et al. Molecular Medicine Reports
- miR-30a-5p in the tumorigenesis of renal cell carcinoma: A tumor suppressive microRNA
- (2016) YIFAN LI et al. Molecular Medicine Reports
- Targeting the cancer epigenome for therapy
- (2016) Peter A. Jones et al. NATURE REVIEWS GENETICS
- The epigenetic landscape of renal cancer
- (2016) Mark R. Morris et al. Nature Reviews Nephrology
- Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy
- (2016) Alain Ravaud et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma
- (2016) NEW ENGLAND JOURNAL OF MEDICINE
- Alcohol and Dietary Folate Intake and Promoter CpG Island Methylation in Clear-Cell Renal Cell Cancer
- (2016) Leo J. Schouten et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Oncogenic cAMP responsive element binding protein 1 is overexpressed upon loss of tumor suppressive miR-10b-5p and miR-363-3p in renal cancer
- (2016) YIFAN LI et al. ONCOLOGY REPORTS
- miR-204 inhibits the proliferation and invasion of renal cell carcinoma by inhibiting RAB22A expression
- (2016) FENG XIONG et al. ONCOLOGY REPORTS
- MicroRNA-21 Regulates the Proliferation, Differentiation, and Apoptosis of Human Renal Cell Carcinoma Cells by the mTOR-STAT3 Signaling Pathway
- (2016) Tao Liang et al. ONCOLOGY RESEARCH
- Genetic predisposition to kidney cancer
- (2016) Laura S. Schmidt et al. SEMINARS IN ONCOLOGY
- MiR-429 is linked to metastasis and poor prognosis in renal cell carcinoma by affecting epithelial-mesenchymal transition
- (2016) Tana Machackova et al. TUMOR BIOLOGY
- Myopodin methylation is a prognostic biomarker and predicts antiangiogenic response in advanced kidney cancer
- (2016) N. Pompas-Veganzones et al. TUMOR BIOLOGY
- H2S and cancer: Give credit where credit is due
- (2016) Csaba Szabo UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Tumor-suppressing effects of microRNA-429 in human renal cell carcinoma via the downregulation of Sp1
- (2016) Deyao Wu et al. Oncology Letters
- Clinical potential of TCF21 methylation in the diagnosis of renal cell carcinoma
- (2016) Jun Xin et al. Oncology Letters
- MicroRNA-27a functions as a tumor suppressor in renal cell carcinoma by targeting epidermal growth factor receptor
- (2016) YUEYAN LI et al. Oncology Letters
- Demethylation drug 5-Aza-2′-deoxycytidine-induced upregulation of miR-200c inhibits the migration, invasion and epithelial-mesenchymal transition of clear cell renal cell carcinoma in vitro
- (2016) JUAN JIANG et al. Oncology Letters
- Mir-451 Correlates with Prognosis of Renal Cell Carcinoma Patients and Inhibits Cellular Proliferation of Renal Cell Carcinoma
- (2016) Shuying Zhu et al. MEDICAL SCIENCE MONITOR
- Cooperative Effect of miR-141-3p and miR-145-5p in the Regulation of Targets in Clear Cell Renal Cell Carcinoma
- (2016) Julia Liep et al. PLoS One
- Epithelial-mesenchymal transition-associated microRNA/mRNA signature is linked to metastasis and prognosis in clear-cell renal cell carcinoma
- (2016) Hana Mlcochova et al. Scientific Reports
- Low Expression of miR-126 Is a Prognostic Marker for Metastatic Clear Cell Renal Cell Carcinoma
- (2015) Heba W.Z. Khella et al. AMERICAN JOURNAL OF PATHOLOGY
- Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
- (2015) Karel G.M. Moons et al. ANNALS OF INTERNAL MEDICINE
- MiRNA-30a-mediated autophagy inhibition sensitizes renal cell carcinoma cells to sorafenib
- (2015) Bing Zheng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Enhancer of zeste homolog 2 (EZH2) promotes tumour cell migration and invasion via epigenetic repression of E-cadherin in renal cell carcinoma
- (2015) Li Liu et al. BJU INTERNATIONAL
- DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts
- (2015) David Roulois et al. CELL
- Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses
- (2015) Katherine B. Chiappinelli et al. CELL
- Promoter Methylation of CDO1 Identifies Clear-Cell Renal Cell Cancer Patients with Poor Survival Outcome
- (2015) I. A. G. Deckers et al. CLINICAL CANCER RESEARCH
- STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies
- (2015) P. M. Bossuyt et al. CLINICAL CHEMISTRY
- Expression of histone methyltransferases as novel biomarkers for renal cell tumor diagnosis and prognostication
- (2015) Ana Sílvia Pires-Luís et al. Epigenetics
- Combination of MiR-378 and MiR-210 Serum Levels Enables Sensitive Detection of Renal Cell Carcinoma
- (2015) Michal Fedorko et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Oncogenic MicroRNAs Characterization in Clear Cell Renal Cell Carcinoma
- (2015) Vincenzo Petrozza et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Decreased expression of RASSF1A tumor suppressor gene is associated with worse prognosis in clear cell renal cell carcinoma
- (2015) JAKUB KLACZ et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Phase I study of the mTOR inhibitor ridaforolimus and the HDAC inhibitor vorinostat in advanced renal cell carcinoma and other solid tumors
- (2015) Matthew Zibelman et al. INVESTIGATIONAL NEW DRUGS
- Long non-coding RNA MEG3 induces renal cell carcinoma cells apoptosis by activating the mitochondrial pathway
- (2015) Miao Wang et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- miR-210 Is a Prognostic Marker in Clear Cell Renal Cell Carcinoma
- (2015) Sara Samaan et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study
- (2015) Jean-Pierre J Issa et al. LANCET ONCOLOGY
- Moving targets: Emerging roles for MMPs in cancer progression and metastasis
- (2015) Gemma Shay et al. MATRIX BIOLOGY
- Loss of histone H3 lysine 36 trimethylation is associated with an increased risk of renal cell carcinoma-specific death
- (2015) Thai H Ho et al. MODERN PATHOLOGY
- The H19 Long non-coding RNA in cancer initiation, progression and metastasis – a proposed unifying theory
- (2015) Eli Raveh et al. Molecular Cancer
- miR-200c Targets CDK2 and Suppresses Tumorigenesis in Renal Cell Carcinoma
- (2015) X. Wang et al. MOLECULAR CANCER RESEARCH
- Tumor suppressive microRNA-429 regulates cellular function by targeting VEGF in clear cell renal cell carcinoma
- (2015) DUQUN CHEN et al. Molecular Medicine Reports
- MicroRNA-21 stimulates epithelial-to-mesenchymal transition and tumorigenesis in clear cell renal cells
- (2015) JIAN CAO et al. Molecular Medicine Reports
- Upregulation of microRNA-204 inhibits cell proliferation, migration and invasion in human renal cell carcinoma cells by downregulating SOX4
- (2015) DEYAO WU et al. Molecular Medicine Reports
- MicroRNA-106b functions as an oncogene in renal cell carcinoma by affecting cell proliferation, migration and apoptosis
- (2015) YIFAN LI et al. Molecular Medicine Reports
- miR-221/222 Are Involved in Response to Sunitinib Treatment in Metastatic Renal Cell Carcinoma
- (2015) Heba W Z Khella et al. MOLECULAR THERAPY
- Molecular genetics and clinical features of Birt–Hogg–Dubé syndrome
- (2015) Laura S. Schmidt et al. Nature Reviews Urology
- Downregulation of microRNA-206 suppresses clear cell renal carcinoma proliferation and invasion by targeting vascular endothelial growth factor A
- (2015) YI CAI et al. ONCOLOGY REPORTS
- MicroRNA-22 functions as a tumor suppressor by targeting SIRT1 in renal cell carcinoma
- (2015) SHOULIN ZHANG et al. ONCOLOGY REPORTS
- Downregulation of miR-19a exhibits inhibitory effects on metastatic renal cell carcinoma by targeting PIK3CA and inactivating Notch signaling in vitro
- (2015) WEI XIAO et al. ONCOLOGY REPORTS
- Epigenetics Meets Immune Checkpoints
- (2015) Alessia Covre et al. SEMINARS IN ONCOLOGY
- miR-106a* inhibits the proliferation of renal carcinoma cells by targeting IRS-2
- (2015) Yadong Ma et al. TUMOR BIOLOGY
- Tumor suppressive microRNA-200a inhibits renal cell carcinoma development by directly targeting TGFB2
- (2015) Ruijing Lu et al. TUMOR BIOLOGY
- High serum miR-183 level is associated with poor responsiveness of renal cancer to natural killer cells
- (2015) Qunmei Zhang et al. TUMOR BIOLOGY
- MicroRNA-429 suppresses cell proliferation, epithelial-mesenchymal transition, and metastasis by direct targeting of BMI1 and E2F3 in renal cell carcinoma
- (2015) Mingning Qiu et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Oncogenic microRNA-142-3p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma
- (2015) YIFAN LI et al. Oncology Letters
- miRNA-target network reveals miR-124as a key miRNA contributing to clear cell renal cell carcinoma aggressive behaviour by targeting CAV1 and FLOT1
- (2015) Henriett Butz et al. Oncotarget
- Integrated genomic analysis identifies subclasses and prognosis signatures of kidney cancer
- (2015) Yann Christinat et al. Oncotarget
- Expression of miR-27a-3p is an independent predictive factor for recurrence in clear cell renal cell carcinoma
- (2015) Wataru Nakata et al. Oncotarget
- Inactivation of bone morphogenetic protein 2 may predict clinical outcome and poor overall survival for renal cell carcinoma through epigenetic pathways
- (2015) Yozo Mitsui et al. Oncotarget
- miR-155 and miR-484 Are Associated with Time to Progression in Metastatic Renal Cell Carcinoma Treated with Sunitinib
- (2015) Jana Merhautova et al. Biomed Research International
- Identification of novel long non-coding RNAs in clear cell renal cell carcinoma
- (2015) Jasmine Blondeau et al. Clinical Epigenetics
- MicroRNA Expression Profiling of Peripheral Blood Samples Predicts Resistance to First-line Sunitinib in Advanced Renal Cell Carcinoma Patients
- (2015) Angelo Gámez-Pozo et al. NEOPLASIA
- MicroRNA-145 Targets the Metalloprotease ADAM17 and Is Suppressed in Renal Cell Carcinoma Patients
- (2015) Kai Doberstein et al. NEOPLASIA
- Emerging roles of miR-210 and other non-coding RNAs in the hypoxic response
- (2014) X. Huang et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Epithelial-to-Mesenchymal Transition in Renal Neoplasms
- (2014) Huiying He et al. ADVANCES IN ANATOMIC PATHOLOGY
- MicroRNA-122 Promotes Proliferation, Invasion and Migration of Renal Cell Carcinoma Cells Through the PI3K/Akt Signaling Pathway
- (2014) Ji-Hu Lian et al. Asian Pacific Journal of Cancer Prevention
- microRNA-183 plays as oncogenes by increasing cell proliferation, migration and invasion via targeting protein phosphatase 2A in renal cancer cells
- (2014) Mingning Qiu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Combination of expression levels of miR-21 and miR-126 is associated with cancer-specific survival in clear-cell renal cell carcinoma
- (2014) Daniel Vergho et al. BMC CANCER
- Investigation of novel circulating proteins, germ line single-nucleotide polymorphisms, and molecular tumor markers as potential efficacy biomarkers of first-line sunitinib therapy for advanced renal cell carcinoma
- (2014) Robert J. Motzer et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- miR-21-3p is a positive regulator of L1CAM in several human carcinomas
- (2014) Kai Doberstein et al. CANCER LETTERS
- miR-28-5p Promotes Chromosomal Instability in VHL-Associated Cancers by Inhibiting Mad2 Translation
- (2014) M. P. Hell et al. CANCER RESEARCH
- MicroRNA-21 (miR-21) Post-Transcriptionally Downregulates Tumor Suppressor PDCD4 and Promotes Cell Transformation, Proliferation, and Metastasis in Renal Cell Carcinoma
- (2014) Xiancheng Li et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- miR-141 Is a Key Regulator of Renal Cell Carcinoma Proliferation and Metastasis by Controlling EphA2 Expression
- (2014) X. Chen et al. CLINICAL CANCER RESEARCH
- microRNA-21-induced dissociation of PDCD4 from rictor contributes to Akt-IKKβ-mTORC1 axis to regulate renal cancer cell invasion
- (2014) Amit Bera et al. EXPERIMENTAL CELL RESEARCH
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- miR-145 functions as tumor suppressor and targets two oncogenes, ANGPT2 and NEDD9, in renal cell carcinoma
- (2014) Ruijing Lu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Expression of the Tumor Suppressive miRNA-23b/27b Cluster is a Good Prognostic Marker in Clear Cell Renal Cell Carcinoma
- (2014) Tomoaki Ishihara et al. JOURNAL OF UROLOGY
- miRNA-34a Suppresses Cell Proliferation and Metastasis by Targeting CD44 in Human Renal Carcinoma Cells
- (2014) Gan Yu et al. JOURNAL OF UROLOGY
- VHL and HIF-1α: gene variations and prognosis in early-stage clear cell renal cell carcinoma
- (2014) Francesca Lessi et al. MEDICAL ONCOLOGY
- Pseudogene PTENP1 Functions as a Competing Endogenous RNA to Suppress Clear-Cell Renal Cell Carcinoma Progression
- (2014) G. Yu et al. MOLECULAR CANCER THERAPEUTICS
- MicroRNA-451a is associated with cell proliferation, migration and apoptosis in renal cell carcinoma
- (2014) ZHENGMING SU et al. Molecular Medicine Reports
- microRNA-145 inhibits cell proliferation, migration and invasion by targeting matrix metallopeptidase-11 in renal cell carcinoma
- (2014) DEYAO WU et al. Molecular Medicine Reports
- microRNA-133b downregulation and inhibition of cell proliferation, migration and invasion by targeting matrix metallopeptidase-9 in renal cell carcinoma
- (2014) DEYAO WU et al. Molecular Medicine Reports
- Unique molecular alteration patterns in von Hippel-Lindau (VHL) gene in a cohort of sporadic renal cell carcinoma patients from Pakistan
- (2014) Shagufta Khaliq et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing
- (2014) Marco Gerlinger et al. NATURE GENETICS
- Histone core modifications regulating nucleosome structure and dynamics
- (2014) Peter Tessarz et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- GATA5 CpG island hypermethylation is an independent predictor for poor clinical outcome in renal cell carcinoma
- (2014) INGA PETERS et al. ONCOLOGY REPORTS
- YY1-C/EBPα-miR34a regulatory circuitry is involved in renal cell carcinoma progression
- (2014) WENHAO WENG et al. ONCOLOGY REPORTS
- MiR-138 Induces Renal Carcinoma Cell Senescence by Targeting EZH2 and Is Downregulated in Human Clear Cell Renal Cell Carcinoma
- (2014) Jiaqian Liang et al. ONCOLOGY RESEARCH
- Correction: Klotho Suppresses Cardiomyocyte Apoptosis in Mice with Stress-Induced Cardiac Injury via Downregulation of Endoplasmic Reticulum Stress
- (2014) Shuang Song et al. PLoS One
- Epigenetic Regulation of Thyroid Hormone Receptor Beta in Renal Cancer
- (2014) Anna Wojcicka et al. PLoS One
- Impact of miR-21, miR-126 and miR-221 as Prognostic Factors of Clear Cell Renal Cell Carcinoma with Tumor Thrombus of the Inferior Vena Cava
- (2014) Daniel Claudius Vergho et al. PLoS One
- Elevated microRNA-185 is associated with high vascular endothelial growth factor receptor 2 expression levels and high microvessel density in clear cell renal cell carcinoma
- (2014) Hai-Xia Yuan et al. TUMOR BIOLOGY
- Suppressed expression of long non-coding RNA HOTAIR inhibits proliferation and tumourigenicity of renal carcinoma cells
- (2014) Yuanhao Wu et al. TUMOR BIOLOGY
- miR-199a-3p inhibits hepatocyte growth factor/c-Met signaling in renal cancer carcinoma
- (2014) Jiwei Huang et al. TUMOR BIOLOGY
- miR-203a regulates proliferation, migration, and apoptosis by targeting glycogen synthase kinase-3β in human renal cell carcinoma
- (2014) Guanghui Hu et al. TUMOR BIOLOGY
- Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma
- (2014) Hai-min Zhang et al. TUMOR BIOLOGY
- Tumor suppressor microRNA-34a inhibits cell proliferation by targeting Notch1 in renal cell carcinoma
- (2014) CHANGCUN ZHANG et al. Oncology Letters
- Exploring the miRNA-mRNA Regulatory Network in Clear Cell Renal Cell Carcinomas by Next-Generation Sequencing Expression Profiles
- (2014) Sören Müller et al. Biomed Research International
- Aberrant Methylation of PCDH8 is a Potential Prognostic Biomarker for Patients with Clear Cell Renal Cell Carcinoma
- (2014) Jian-Guo Ma MEDICAL SCIENCE MONITOR
- Neurofilament Heavy polypeptideCpG island methylation associates with prognosis of renal cell carcinoma and prediction of antivascular endothelial growth factor therapy response
- (2014) Natalia Dubrowinskaja et al. Cancer Medicine
- miRNA-205 Is a Candidate Tumor Suppressor that Targets ZEB2 in Renal Cell Carcinoma
- (2014) Zhi Chen et al. Oncology Research and Treatment
- Long Non-coding RNA GAS5 Functions as a Tumor Suppressor in Renal Cell Carcinoma
- (2013) Hui-Ping Qiao et al. Asian Pacific Journal of Cancer Prevention
- miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis
- (2013) R I McCormick et al. BRITISH JOURNAL OF CANCER
- MicroRNA profile: a promising ancillary tool for accurate renal cell tumour diagnosis
- (2013) R M Silva-Santos et al. BRITISH JOURNAL OF CANCER
- Genomics and epigenomics of clear cell renal cell carcinoma: Recent developments and potential applications
- (2013) Małgorzata Rydzanicz et al. CANCER LETTERS
- Hypoxia-induced downregulation of miR-30c promotes epithelial-mesenchymal transition in human renal cell carcinoma
- (2013) Jiwei Huang et al. CANCER SCIENCE
- Epigenetic alterations of Krüppel-like factor 4 and its tumor suppressor function in renal cell carcinoma
- (2013) Heng Li et al. CARCINOGENESIS
- miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma
- (2013) H.W.Z. Khella et al. CARCINOGENESIS
- MiR-30d induces apoptosis and is regulated by the Akt/FOXO pathway in renal cell carcinoma
- (2013) Chenglin Wu et al. CELLULAR SIGNALLING
- The Effect of VEGF-Targeted Therapy on Biomarker Expression in Sequential Tissue from Patients with Metastatic Clear Cell Renal Cancer
- (2013) K. Sharpe et al. CLINICAL CANCER RESEARCH
- Adverse Outcomes in Clear Cell Renal Cell Carcinoma with Mutations of 3p21 Epigenetic Regulators BAP1 and SETD2: A Report by MSKCC and the KIRC TCGA Research Network
- (2013) A. A. Hakimi et al. CLINICAL CANCER RESEARCH
- Clinical and pathological impact ofVHL, PBRM1, BAP1, SETD2, KDM6A, andJARID1cin clear cell renal cell carcinoma
- (2013) Lucy Gossage et al. GENES CHROMOSOMES & CANCER
- Hypoxia-induced epigenetic modifications are associated with cardiac tissue fibrosis and the development of a myofibroblast-like phenotype
- (2013) Chris J. Watson et al. HUMAN MOLECULAR GENETICS
- Serum miR-210 as a potential biomarker of early clear cell renal cell carcinoma
- (2013) HIDETO IWAMOTO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Epithelial–mesenchymal transition-related microRNA-200s regulate molecular targets and pathways in renal cell carcinoma
- (2013) Hirofumi Yoshino et al. JOURNAL OF HUMAN GENETICS
- MicroRNA-218 Inhibits Cell Migration and Invasion in Renal Cell Carcinoma through Targeting Caveolin-2 Involved in Focal Adhesion Pathway
- (2013) Takeshi Yamasaki et al. JOURNAL OF UROLOGY
- External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study
- (2013) Daniel YC Heng et al. LANCET ONCOLOGY
- Integrated molecular analysis of clear-cell renal cell carcinoma
- (2013) Yusuke Sato et al. NATURE GENETICS
- Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer
- (2013) W Kong et al. ONCOGENE
- microRNA-200c modulates the epithelial-to-mesenchymal transition in human renal cell carcinoma metastasis
- (2013) XUEGANG WANG et al. ONCOLOGY REPORTS
- Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2
- (2013) S. K. Knutson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Proliferation inhibition and the underlying molecular mechanisms of microRNA-30d in renal carcinoma cells
- (2013) HONGSHENG YU et al. Oncology Letters
- Differential microRNA expression in renal cell carcinoma
- (2013) TINGTING CHENG et al. Oncology Letters
- Tumour angiogenesis regulation by the miR-200 family
- (2013) Chad V. Pecot et al. Nature Communications
- Restricted Expression of miR-30c-2-3p and miR-30a-3p in Clear Cell Renal Cell Carcinomas Enhances HIF2 Activity
- (2013) L. K. Mathew et al. Cancer Discovery
- The enhancer of zeste homolog 2 (EZH2), a potential therapeutic target, is regulated by miR-101 in renal cancer cells
- (2012) Toshihiko Sakurai et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- GATA5CpG island methylation in renal cell cancer: a potential biomarker for metastasis and disease progression
- (2012) Inga Peters et al. BJU INTERNATIONAL
- Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration
- (2012) Douglas G Altman et al. BMC Medicine
- VHL-Regulated MiR-204 Suppresses Tumor Growth through Inhibition of LC3B-Mediated Autophagy in Renal Clear Cell Carcinoma
- (2012) Olga Mikhaylova et al. CANCER CELL
- Analysis of serum microRNAs (miR-26a-2*, miR-191, miR-337-3p and miR-378) as potential biomarkers in renal cell carcinoma
- (2012) Stefan Hauser et al. Cancer Epidemiology
- Multilevel Whole-Genome Analysis Reveals Candidate Biomarkers in Clear Cell Renal Cell Carcinoma
- (2012) A. H. Girgis et al. CANCER RESEARCH
- Tumor-suppressivemicroRNA-135ainhibits cancer cell proliferation by targeting thec-MYConcogene in renal cell carcinoma
- (2012) Yasutoshi Yamada et al. CANCER SCIENCE
- Cancer Epigenetics: From Mechanism to Therapy
- (2012) Mark A. Dawson et al. CELL
- The many faces and functions of β-catenin
- (2012) Tomas Valenta et al. EMBO JOURNAL
- Genome-wide CpG island methylation analysis implicates novel genes in the pathogenesis of renal cell carcinoma
- (2012) Christopher J. Ricketts et al. Epigenetics
- SFRP1CpG island methylation locus is associated with renal cell cancer susceptibility and disease recurrence
- (2012) Faranaz Atschekzei et al. Epigenetics
- Clinical and Pathologic Impact of Select Chromatin-modulating Tumor Suppressors in Clear Cell Renal Cell Carcinoma
- (2012) A. Ari Hakimi et al. EUROPEAN UROLOGY
- Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma
- (2012) An Zhao et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Identification of MicroRNAs associated with early relapse after nephrectomy in renal cell carcinoma patients
- (2012) Ondrej Slaby et al. GENES CHROMOSOMES & CANCER
- Tumor suppressive microRNA-138 contributes to cell migration and invasion through its targeting of vimentin in renal cell carcinoma
- (2012) TAKESHI YAMASAKI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- MicroRNA-155 is a predictive marker for survival in patients with clear cell renal cell carcinoma
- (2012) Shunsuke Shinmei et al. INTERNATIONAL JOURNAL OF UROLOGY
- A phase I study of sorafenib and vorinostat in patients with advanced solid tumors with expanded cohorts in renal cell carcinoma and non-small cell lung cancer
- (2012) A. Dasari et al. INVESTIGATIONAL NEW DRUGS
- The Clinical Utility of miR-21 as a Diagnostic and Prognostic Marker for Renal Cell Carcinoma
- (2012) Hala Faragalla et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma
- (2012) Martina Redova et al. Journal of Translational Medicine
- A Possible Role for MicroRNA-141 Down-Regulation in Sunitinib Resistant Metastatic Clear Cell Renal Cell Carcinoma Through Induction of Epithelial-to-Mesenchymal Transition and Hypoxia Resistance
- (2012) Joost Berkers et al. JOURNAL OF UROLOGY
- microRNA-155 silencing inhibits proliferation and migration and induces apoptosis by upregulating BACH1 in renal cancer cells
- (2012) SONGCHAO LI et al. Molecular Medicine Reports
- BAP1 loss defines a new class of renal cell carcinoma
- (2012) Samuel Peña-Llopis et al. NATURE GENETICS
- TGFβ signalling in context
- (2012) Joan Massagué NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Correction: Up-Regulation of MicroRNA-21 Correlates with Lower Kidney Cancer Survival
- (2012) Mohd Saif Zaman et al. PLoS One
- Genome-Wide MicroRNA Expression Analysis of Clear Cell Renal Cell Carcinoma by Next Generation Deep Sequencing
- (2012) Susanne Osanto et al. PLoS One
- An overview of renal cell cancer: Pathology and genetics
- (2012) Holger Moch SEMINARS IN CANCER BIOLOGY
- Genomics and epigenomics of renal cell carcinoma
- (2012) Eamonn R. Maher SEMINARS IN CANCER BIOLOGY
- MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma
- (2012) Martina Redova et al. TUMOR BIOLOGY
- miR-21 Downregulated TCF21 to Inhibit KISS1 in Renal Cancer
- (2012) Hui Zhang et al. UROLOGY
- Primary anti-vascular endothelial growth factor (VEGF)-refractory metastatic renal cell carcinoma: clinical characteristics, risk factors, and subsequent therapy
- (2011) D. Y. Heng et al. ANNALS OF ONCOLOGY
- Global histone H3 lysine 27 (H3K27) methylation levels and their prognostic relevance in renal cell carcinoma
- (2011) Sebastian Rogenhofer et al. BJU INTERNATIONAL
- Phase I study of the histone deacetylase inhibitor entinostat in combination with 13-cis retinoic acid in patients with solid tumours
- (2011) R Pili et al. BRITISH JOURNAL OF CANCER
- Serum cell-free DNA in renal cell carcinoma
- (2011) Michela de Martino et al. CANCER
- A Phase II Trial of Panobinostat, a Histone Deacetylase Inhibitor, in the Treatment of Patients with Refractory Metastatic Renal Cell Carcinoma
- (2011) John D. Hainsworth et al. CANCER INVESTIGATION
- Re-expression of miR-199a suppresses renal cancer cell proliferation and survival by targeting GSK-3β
- (2011) Masaaki Tsukigi et al. CANCER LETTERS
- MicroRNA-708 Induces Apoptosis and Suppresses Tumorigenicity in Renal Cancer Cells
- (2011) S. Saini et al. CANCER RESEARCH
- MicroRNA-205 Inhibits Src-Mediated Oncogenic Pathways in Renal Cancer
- (2011) S. Majid et al. CANCER RESEARCH
- MicroRNA-34a suppresses malignant transformation by targeting c-Myc transcriptional complexes in human renal cell carcinoma
- (2011) Soichiro Yamamura et al. CARCINOGENESIS
- Analysis of Promoter CpG Island Hypermethylation in Cancer: Location, Location, Location!
- (2011) I. J. H. van Vlodrop et al. CLINICAL CANCER RESEARCH
- TCF21andPCDH17methylation: An innovative panel of biomarkers for a simultaneous detection of urological cancers
- (2011) Vera L. Costa et al. Epigenetics
- The functional significance of miR-1 and miR-133a in renal cell carcinoma
- (2011) Kazumori Kawakami et al. EUROPEAN JOURNAL OF CANCER
- Overexpression of miR-210, a downstream target of HIF1α, causes centrosome amplification in renal carcinoma cells
- (2011) Chisato Nakada et al. JOURNAL OF PATHOLOGY
- miRNA Profiling for Clear Cell Renal Cell Carcinoma: Biomarker Discovery and Identification of Potential Controls and Consequences of miRNA Dysregulation
- (2011) Nicole M.A. White et al. JOURNAL OF UROLOGY
- Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma
- (2011) Ignacio Varela et al. NATURE
- A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma
- (2011) Corine Bertolotto et al. NATURE
- Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma
- (2011) Guangwu Guo et al. NATURE GENETICS
- The complex roles of Wnt antagonists in RCC
- (2011) Sharanjot Saini et al. Nature Reviews Urology
- Methylation of the APAF-1 and DAPK-1 promoter region correlates with progression of renal cell carcinoma in North Indian population
- (2011) Shiekh Tanveer Ahmad et al. TUMOR BIOLOGY
- Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas
- (2011) Markus Vogt et al. VIRCHOWS ARCHIV
- Von Hippel-Lindau (VHL) Inactivation in Sporadic Clear Cell Renal Cancer: Associations with Germline VHL Polymorphisms and Etiologic Risk Factors
- (2011) Lee E. Moore et al. PLoS Genetics
- DNA hypermethylation in papillary renal cell carcinoma
- (2010) Jörg Ellinger et al. BJU INTERNATIONAL
- Gremlin is a novel agonist of the major proangiogenic receptor VEGFR2
- (2010) S. Mitola et al. BLOOD
- Safety and efficacy results of the advanced renal cell carcinoma sorafenib expanded access program in North America
- (2010) Walter M. Stadler et al. CANCER
- Signaling pathways in renal cell carcinoma
- (2010) Gowrishankar Banumathy et al. CANCER BIOLOGY & THERAPY
- Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer
- (2010) Dmitri Lodygin et al. CELL CYCLE
- Functional Genomics Reveals a BMP-Driven Mesenchymal-to-Epithelial Transition in the Initiation of Somatic Cell Reprogramming
- (2010) Payman Samavarchi-Tehrani et al. Cell Stem Cell
- Functional and Epigenetic Characterization of the KRT19 Gene in Renal Cell Neoplasms
- (2010) Filipa Paiva et al. DNA AND CELL BIOLOGY
- Loss of expression of TIMP3 in clear cell renal cell carcinoma
- (2010) Damien Masson et al. EUROPEAN JOURNAL OF CANCER
- Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma
- (2010) Hiroshi Hirata et al. INTERNATIONAL JOURNAL OF CANCER
- Prognostic relevance of global histone H3 lysine 4 (H3K4) methylation in renal cell carcinoma
- (2010) Jörg Ellinger et al. INTERNATIONAL JOURNAL OF CANCER
- Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy
- (2010) Ondrej Slaby et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Aberrant Promoter Methylation of DLEC1, a Critical 3p22 Tumor Suppressor for Renal Cell Carcinoma, is Associated With More Advanced Tumor Stage
- (2010) Qian Zhang et al. JOURNAL OF UROLOGY
- Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
- (2010) Gillian L. Dalgliesh et al. NATURE
- Targeting microRNAs in cancer: rationale, strategies and challenges
- (2010) Ramiro Garzon et al. NATURE REVIEWS DRUG DISCOVERY
- Identification of candidate tumour suppressor genes frequently methylated in renal cell carcinoma
- (2010) M R Morris et al. ONCOGENE
- Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma
- (2010) M R Morris et al. ONCOGENE
- Wnt signal transduction pathways
- (2010) Yuko Komiya et al. Organogenesis
- Epigenetics of renal cell carcinoma: the path towards new diagnostics and therapeutics
- (2010) Mark R Morris et al. Genome Medicine
- Global Levels of Histone Modifications Predict Prognosis in Different Cancers
- (2009) David B. Seligson et al. AMERICAN JOURNAL OF PATHOLOGY
- Prognostic Significance of Gremlin1 (GREM1) Promoter CpG Island Hypermethylation in Clear Cell Renal Cell Carcinoma
- (2009) Iris J.H. van Vlodrop et al. AMERICAN JOURNAL OF PATHOLOGY
- Methylation level of the RASSF1A promoter is an independent prognostic factor for clear-cell renal cell carcinoma
- (2009) Y. Kawai et al. ANNALS OF ONCOLOGY
- Absence of VHL gene alteration and high VEGF expression are associated with tumour aggressiveness and poor survival of renal-cell carcinoma
- (2009) J-J Patard et al. BRITISH JOURNAL OF CANCER
- TGF-β-induced epithelial to mesenchymal transition
- (2009) Jian Xu et al. CELL RESEARCH
- Analysis of VHL Gene Alterations and their Relationship to Clinical Parameters in Sporadic Conventional Renal Cell Carcinoma
- (2009) A. C. Young et al. CLINICAL CANCER RESEARCH
- MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy
- (2009) Monika Jung et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study
- (2009) Daniel Y.C. Heng et al. JOURNAL OF CLINICAL ONCOLOGY
- Resistance to targeted therapy in renal-cell carcinoma
- (2009) Brian I Rini et al. LANCET ONCOLOGY
- Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer
- (2009) Gijs van Haaften et al. NATURE GENETICS
- The SWI/SNF complex and cancer
- (2009) D Reisman et al. ONCOGENE
- Multigene Methylation Analysis of Conventional Renal Cell Carcinoma
- (2009) H. Onay et al. UROLOGIA INTERNATIONALIS
- Polybromo-1: The chromatin targeting subunit of the PBAF complex
- (2008) Martin Thompson BIOCHIMIE
- Functional epigenomics approach to identify methylated candidate tumour suppressor genes in renal cell carcinoma
- (2008) M R Morris et al. BRITISH JOURNAL OF CANCER
- A Phase 1 Pharmacokinetic and Pharmacodynamic Study of the Histone Deacetylase Inhibitor Belinostat in Patients with Advanced Solid Tumors
- (2008) N. L. Steele et al. CLINICAL CANCER RESEARCH
- Genetic Clustering of Clear Cell Renal Cell Carcinoma Based on Array-Comparative Genomic Hybridization: Its Association with DNA Methylation Alteration and Patient Outcome
- (2008) E. Arai et al. CLINICAL CANCER RESEARCH
- Genetic and Epigenetic Alterations in the von Hippel-Lindau Gene: the Influence on Renal Cancer Prognosis
- (2008) K. M. Smits et al. CLINICAL CANCER RESEARCH
- External Validation of the Mayo Clinic Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear-Cell Renal Cell Carcinoma in a Single European Centre Applying Routine Pathology
- (2008) Richard Zigeuner et al. EUROPEAN UROLOGY
- Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c
- (2008) C Nakada et al. JOURNAL OF PATHOLOGY
- CpG Hypermethylation of the UCHL1 Gene Promoter is Associated With Pathogenesis and Poor Prognosis in Renal Cell Carcinoma
- (2008) Ichiro Kagara et al. JOURNAL OF UROLOGY
- Identification of protein-coding and intronic noncoding RNAs down-regulated in clear cell renal carcinoma
- (2008) Glauber Costa Brito et al. MOLECULAR CARCINOGENESIS
- The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
- (2008) Philip A. Gregory et al. NATURE CELL BIOLOGY
- Epigenetics in Cancer
- (2008) Manel Esteller NEW ENGLAND JOURNAL OF MEDICINE
- Comparative Promoter Methylation Analysis of p53 Target Genes in Urogenital Cancers
- (2008) Frank Christoph et al. UROLOGIA INTERNATIONALIS
- Inactivation of p16 by CpG hypermethylation in renal cell carcinoma
- (2007) Marta Vidaurreta et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation